Thomas Seeholzer
Helmholtz Zentrum München(DE)Fraunhofer Institute for Translational Medicine and Pharmacology(DE)
Publications by Year
Research Areas
NF-κB Signaling Pathways, Antibiotic Resistance in Bacteria, Cell death mechanisms and regulation, Immune Response and Inflammation, Ubiquitin and proteasome pathways
Most-Cited Works
- → Alternative splicing of MALT1 controls signalling and activation of CD4+ T cells(2016)100 cited
- → Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation(2019)84 cited
- → Molecular architecture and regulation of BCL10-MALT1 filaments(2018)71 cited
- → Human TH17 cells engage gasdermin E pores to release IL-1α on NLRP3 inflammasome activation(2023)64 cited
- → BCL10 – Bridging CARDs to Immune Activation(2018)56 cited
- → Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas(2016)45 cited
- → TRAF6 prevents fatal inflammation by homeostatic suppression of MALT1 protease(2021)31 cited
- → A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells(2022)26 cited
- → Microbial dysbiosis in a mouse model of atopic dermatitis mimics shifts in human microbiome and correlates with the key pro‐inflammatory cytokines IL‐4, IL‐33 and TSLP(2022)20 cited
- → Human immune disorder associated with homozygous hypomorphic mutation affecting MALT1B splice variant(2020)19 cited